Skip to content
Get the Balanced News app for a better experience!
The Balanced News Logo
Analytics
The Balanced News Logo

Stay Balanced, Stay Informed

Menu
  • Browse News
  • Underreported Stories
  • Curated Feeds
  • Insights
  • Analytics
  • Our Writers
  • About Us
  • Download App
Learn
  • How It Works
  • Bias Detection
  • Lens Score
  • Source Bias Checker
  • Accountability
  • Custom Feeds
Newsroom
  • Writers & Analysts
  • About TBN
  • Editorial Standards
  • Corrections Policy
  • Our Partners
  • Insights
Socials
  • Youtube
  • Instagram
  • X
  • Facebook
News Categories
  • Trending
  • Politics
  • Sports
  • Business
  • Tech
  • Entertainment
  • Health
  • Science
  • Crime
  • Lifestyle
  • National
  • International
  • Good News
  • Crypto

Get Our App

Available for iOS and Android


LensFeedsInsightsAnalyticsTrendingGood NewsSportsPoliticsBusinessCrimeTechEntertainmentHealthNationalInternational

© 2026 The Balanced News. All rights reserved.

About UsEditorial StandardsCorrectionsHelp & SupportPrivacy PolicyTerms & Conditions
Torrent Pharmaceuticals Q2 Net Profit Falls 9.6% Amid 51% Revenue Growth

Categories

Categories

Related Coverage

Select a news story to see related coverage from other media outlets.

Related Coverage

Select a news story to see related coverage from other media outlets.

  1. Home
  2. /
  3. Business

Torrent Pharmaceuticals Q2 Net Profit Falls 9.6% Amid 51% Revenue Growth

Analysed 23 Oct 2026·3 sources analysed·Torrent, Valencia, Spain·Business
Torrent Pharmaceuticals Q2 Net Profit Falls 9.6% Amid 51% Revenue GrowthPreviousNext

Torrent Pharmaceuticals reported a 9.64% decline in consolidated net profit to Rs 534 crore for Q2 FY27, down from Rs 591 crore a year earlier. Despite this, total revenue rose 50.78% to Rs 4,979 crore, driven by increases in India, US, and Brazil markets, while Germany revenue fell 7%. Expenses also rose significantly to Rs 4,222 crore. For the first half of FY27, net profit decreased 3.42% to Rs 1,100 crore compared to the previous year.

Sentiment
50%
TBN's observations

First-hand measurement across 3 sources

We measured how 3 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is neutral (50/100). Lens Score 36/100.

Outlets measured: businessstandard, freepressjournal, news18. See how each one headlined and framed the same story in the source comparison below.

AI analysis of 3 sources · Published under editorial oversight by The Balanced News
Analysed 23 Oct 2026· How this analysis is produced· Editorial standards· Corrections

AI Analysis

Sentiment — Neutral (50/100)

Sentiment was consistent across outlets (50–50/100), indicating broadly factual reporting rather than editorialising.

Coverage timeline

news18 broke this story on 23 Oct, 12:18 pm. Other outlets followed.

23 Oct, 12:18 pm3 sources · 2 h23 Oct, 01:49 pm
AI analysis by the TBN Bias Engine · beat methodology byMrunal Wange· Business & Economy Editor· editorial standards byOjas Kale
← Previous
Binance's AI Security Systems Prevent $4.6 Billion in Crypto Losses in Early 2026
Next →
DCB Bank and CSB Bank Report Profit Growth and Improved Asset Quality in Q2 FY27
  1. 1
    news1823 Oct, 12:18 pm
    Torrent Pharma Q2 net profit drops 9.6 pc to Rs 534 cr, revenue up nearly 51 pc
  2. 2
    freepressjournal23 Oct, 01:25 pm
    Torrent Pharmaceuticals Q2 Results FY27: Net Profit Falls 9.64 To 534 Crore Despite 50.78 Revenue Growth
  3. 3
    businessstandard23 Oct, 01:49 pm
    Torrent Pharma Q2 profit falls 9.6 to 534 crore, revenue rises 51

Who's involved

Institutions and figures named across source coverage.

Corporate
Torrent Pharmaceuticals Limited

Story context

Category
Business
Location
Torrent, Valencia, Spain
Sources analysed
3
Last analysed
23 Oct 2026
Key entities
Torrent PharmaceuticalsCroreIndian rupeeIndiaBrazilNew DelhiGermanyTorrent, ValenciaDahej PortFood and Drug AdministrationPress Trust of IndiaNet income